Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 10Phase 1/2 5Phase EARLY_PHASE1 4Phase 1 4Phase 4 2

Status

Completed 5Unknown 4Active not recruiting 4Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

NET 4Endocrine 4Thoracic 1

Conditions

Multiple Myeloma 26Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 15Lymphoma, B-Cell 15Prostatic Neoplasms 14Stomach Neoplasms 12Carcinoma, Hepatocellular 12Recurrence 11Lung Neoplasms 11Burkitt Lymphoma 11Solid Tumor 10Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Sarcoma 6Polycystic Ovary Syndrome 6Glioma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Interventions

lanreotide 1gallium Ga 68 dotatate 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Neuroendocrine Tumors × Clear all
NCT04897542 2023-09-18

Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02817945 2022-04-07

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNETThoracic

Lung Neoplasms, Neuroendocrine Tumors

NCT02823691 2021-06-07

MetNET-2

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase EARLY_PHASE1 Unknown
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04041882 2019-08-01

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡